We are live on ! Find out more
AC

Amici Capital Portfolio holdings

AUM $257M
1-Year Est. Return 4.88%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+4.88%
3 Year Est. Return
+28.64%
5 Year Est. Return
10 Year Est. Return
AUM
$2.75B
AUM Growth
-$38.2M
Cap. Flow
-$190M
Cap. Flow %
-6.93%
Top 10 Hldgs %
35.38%
Holding
161
New
32
Increased
29
Reduced
31
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 23.53%
2 Financials 13.46%
3 Communication Services 9.64%
4 Consumer Discretionary 9.47%
5 Technology 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEI
101
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$1.07M 0.04%
+3,333
New +$1.12M
SQNM
102
DELISTED
SEQUENOM INC NEW
SQNM
$1.06M 0.04%
350,000
+300,000
+600% +$1.13M
AAMC
103
DELISTED
Altisource Asset Management Corp
AAMC
$1.05M 0.04%
12,344
MHFI
104
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$1M 0.04%
10,000
YHOO
105
DELISTED
Yahoo Inc
YHOO
$982K 0.04%
25,000
-5,000
-17% -$215K
MCO icon
106
Moody's
MCO
$82.8B
$918K 0.03%
8,500
VMC icon
107
CALL
Vulcan Materials
VMC
$34.8B
$839K 0.03%
+10,000
New +$872K
BABA icon
108
Alibaba
BABA
$293B
$823K 0.03%
10,000
-5,000
-33% -$430K
RGLS
109
DELISTED
Regulus Therapeutics
RGLS
$822K 0.03%
+625
New +$1.01M
OTIC
110
DELISTED
Otonomy, Inc.
OTIC
$736K 0.03%
+32,000
New +$897K
ARCC icon
111
Ares Capital
ARCC
$13.5B
$647K 0.02%
39,291
C icon
112
Citigroup
C
$222B
$629K 0.02%
11,390
TVTY
113
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$625K 0.02%
+52,200
New +$867K
SRPT icon
114
Sarepta Therapeutics
SRPT
$1.57B
$583K 0.02%
19,150
ALGN icon
115
Align Technology
ALGN
$12.1B
$569K 0.02%
9,072
RAMP icon
116
LiveRamp
RAMP
$2.3B
$563K 0.02%
+32,000
New +$575K
SGMO
117
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$444K 0.02%
+40,000
New +$516K
OCUL icon
118
Ocular Therapeutix
OCUL
$1.79B
$421K 0.02%
+20,000
New +$496K
FNFV
119
DELISTED
Fidelity Natl Financial, Inc.
FNFV
$368K 0.01%
23,948
ALU
120
DELISTED
Alcatel-Lucent
ALU
$333K 0.01%
92,000
EXEL icon
121
Exelixis
EXEL
$13.3B
$327K 0.01%
87,000
TPST icon
122
Tempest Therapeutics
TPST
$13.7M
$289K 0.01%
+3
New +$275K
SPPI
123
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$103K ﹤0.01%
15,000
LXRX icon
124
Lexicon Pharmaceuticals
LXRX
$1.03B
$101K ﹤0.01%
12,515
REMY
125
DELISTED
REMY INTL INC NEW COMMON
REMY
$95K ﹤0.01%
4,281

Similar funds

Amici Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Amici Capital held 161 positions worth $2.75B, down 1.4% from $2.78B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Amici Capital withdrew a net $190M in Q2 2015, closing 25 positions and reducing 31 holdings. Its most notable exit was Graham Holdings Company, an estimated $40M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Amici Capital opened a new position in MGIC Investment worth $42.8M.

  • Amici Capital's largest Q2 2015 buy was MGIC Investment: 3,760,000 shares worth $42.8M.
  • Amici Capital added most to Alphabet (Google) Class C in Q2 2015, an estimated $40.5M increase.
  • Amici Capital's biggest Q2 2015 reduction was Endurance International Group Holdings, Inc., cutting an estimated $40.9M.
  • Amici Capital fully exited Graham Holdings Company in Q2 2015, selling an estimated $40M.
  • Amici Capital's ten largest holdings make up 35% of its $2.75B portfolio in Q2 2015.
  • Amici Capital opened 32 new positions and closed 25 in Q2 2015.
  • Amici Capital's portfolio value fell 1.4% quarter-over-quarter to $2.75B.

Based on Amici Capital's 13F filing for Q2 2015, filed 14 Aug 2015.